EPEG Trademark

Trademark Overview


On Wednesday, September 7, 2005, a trademark application was filed for EPEG with the United States Patent and Trademark Office. The USPTO has given the EPEG trademark a serial number of 78708605. The federal status of this trademark filing is REGISTERED AND RENEWED as of Sunday, October 22, 2017. This trademark is owned by Prolong Pharmaceuticals, Inc.. The EPEG trademark is filed in the Pharmaceutical Products category with the following description:

Erythropoietin hormones
epeg

General Information


Serial Number78708605
Word MarkEPEG
Filing DateWednesday, September 7, 2005
Status800 - REGISTERED AND RENEWED
Status DateSunday, October 22, 2017
Registration Number3299299
Registration DateTuesday, September 25, 2007
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 5, 2006

Trademark Statements


Goods and ServicesErythropoietin hormones

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, September 15, 2005
Primary Code005
First Use Anywhere DateTuesday, May 31, 2005
First Use In Commerce DateWednesday, November 30, 2005

Trademark Owner History


Party NamePROLONG PHARMACEUTICALS, LLC
Party Type31 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressSOUTH PLAINFIELD, NJ 07080

Party NameProlong Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressMonmouth Junction, NJ 08852

Party NameProlong Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMonmouth Junction, NJ 08852

Party NameProlong Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMonmouth Junction, NJ 08852

Trademark Events


Event DateEvent Description
Sunday, October 22, 2017NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Sunday, October 22, 2017REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Sunday, October 22, 2017REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Sunday, October 22, 2017CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, September 25, 2017TEAS SECTION 8 & 9 RECEIVED
Sunday, September 25, 2016COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Friday, June 19, 2015NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Friday, June 19, 2015REGISTERED - SEC. 8 (6-YR) ACCEPTED
Tuesday, September 23, 2014TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Wednesday, April 9, 2014POST REGISTRATION ACTION MAILED - SEC. 8
Tuesday, March 25, 2014CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, March 11, 2014TEAS SECTION 8 RECEIVED
Wednesday, December 22, 2010AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, September 25, 2007REGISTERED-PRINCIPAL REGISTER
Monday, August 20, 2007LAW OFFICE REGISTRATION REVIEW COMPLETED
Monday, August 20, 2007ASSIGNED TO LIE
Friday, July 6, 2007ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, June 27, 2007STATEMENT OF USE PROCESSING COMPLETE
Monday, March 19, 2007USE AMENDMENT FILED
Monday, March 19, 2007PAPER RECEIVED
Tuesday, February 27, 2007NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 5, 2006PUBLISHED FOR OPPOSITION
Wednesday, November 15, 2006NOTICE OF PUBLICATION
Thursday, October 12, 2006LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, October 6, 2006ASSIGNED TO LIE
Thursday, October 5, 2006APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, September 14, 2006AMENDMENT FROM APPLICANT ENTERED
Tuesday, August 29, 2006CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 29, 2006PAPER RECEIVED
Wednesday, March 22, 2006NON-FINAL ACTION E-MAILED
Wednesday, March 22, 2006NON-FINAL ACTION WRITTEN
Monday, March 20, 2006ASSIGNED TO EXAMINER
Thursday, September 15, 2005NEW APPLICATION ENTERED IN TRAM

Related Keywords


epeg hormones erythropoietin